Head-to-head for women
Found vs yourEra
Found and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Found
Ranked #10 for women · Grade B
Luna Fit
Best for: Women who have (or might qualify for) insurance that covers GLP-1s and want a marketplace that shops that benefit for them, or who'd rather take an oral pill (Rybelsus) than inject.
Visit FoundyourEra
Higher scoreRanked #3 for women · Grade B
Luna Fit
Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.
Visit yourEraThe verdict for women
yourEra edges out Found on the Luna Fit Score, 86 to 84 (B vs B). Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account. The reasoning behind that number is in our full yourEra review.
Found is still a genuine option — an insurance-first GLP-1 marketplace that shops a reader's coverage for her — down to $99/mo with qualifying insurance, or $50/mo for eligible Medicare Part D members through its CMS Bridge program — with one of the widest medication menus on this board, including an oral pill option. Weigh the six women's-health factors below against your own priorities; the Found scorecard goes through each of them, and if neither of these two is the one, the Found alternatives, scored on the same six factors widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Found | yourEra |
|---|---|---|
| Luna Fit Score | 84/100 · B | 86/100 · B |
| Overall rank | #10 | #3 |
| Semaglutide | $169/mo cash-pay (multi-month plan) — as low as $99/mo with qualifying insurance, or $289/mo cash-pay billed month-to-month; compounded, flat price at every dose (Found does not publish a separate semaglutide-specific rate) | $199/mo |
| Tirzepatide | $169/mo cash-pay (multi-month plan) — as low as $99/mo with qualifying insurance, or $289/mo cash-pay billed month-to-month; compounded, flat price at every dose (Found does not publish a separate tirzepatide-specific rate) | $299/mo |
| Coverage | All 50 states (self-pay); insurance-plan availability varies by state — California showed no in-network insurance plans as of 2026-08-04 | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
Found
Ranked #10 · Grade B
What we like
- Insurance-based pricing can bring the real monthly cost to $99/mo, and eligible Medicare Part D members can get brand-name Wegovy, Zepbound or Foundayo for a flat $50/mo copay via Found's CMS GLP-1 Bridge program (through Dec 2027)
- One of the broadest medication catalogs on this board — 15+ named products including oral Rybelsus, injectable Wegovy, Zepbound, Ozempic, Mounjaro and Foundayo, plus compounded semaglutide and tirzepatide
- No lock-in on the subscription itself — cancel anytime per its own terms, effective within 24 hours
The caveats
- Compounded semaglutide and tirzepatide are not priced separately anywhere on the site — you get a plan-tier rate ($99–$289/mo depending on insurance and commitment), not a molecule-specific figure
- The lowest cash-pay rate ($169/mo) requires committing to a multi-month plan up front; paying month-to-month without insurance runs $289/mo
- Subscription fees are stated non-refundable in Found's own terms, with refunds granted only at its discretion
Luna Fit
yourEra
Ranked #3 · Grade B
What we like
- Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
- Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
- Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
- Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
- Injectable only — no oral route and no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Found nor yourEra is only worth comparing with the other. Found is also written up against Eden, 6 points apart on the Luna Fit Score — see how Found and Eden compare on the Luna Fit Score. yourEra is also written up against CoreAge Rx, 7 points apart — see how yourEra and CoreAge Rx compare on the Luna Fit Score.
- Found vs CoreAge Rx
- Found vs Enhance MD
- Found vs Sesame Care
- yourEra vs HealthRX
- yourEra vs Strut Health
- yourEra vs MadeMed
Or browse the full comparison hub.